摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 14973-66-1

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
14973-66-1;75331-96-3
化学式
C14H16Cl4N2O4Re2
mdl
——
分子量
790.518
InChiKey
RTOZAJHHVHKGGK-UHFFFAOYSA-H
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    在 P(CH3)3 作用下, 以 乙醇 为溶剂, 以57%的产率得到Dichlororhenium;trimethylphosphane
    参考文献:
    名称:
    Chakravarty, Akhil R.; Cotton, F. Albert; Cutler, Ann R., Inorganic Chemistry, 1986, vol. 25, # 20, p. 3619 - 3624
    摘要:
    DOI:
  • 作为产物:
    描述:
    cis-dirhenium diacetate tetrachloride dihydrate吡啶 作用下, 以 溶剂黄146丙酮 为溶剂, 以90%的产率得到
    参考文献:
    名称:
    Misailova, T. V.; Kotel'nikova, A. S.; Golovaneva, I. F., Russian Journal of Inorganic Chemistry, 1981, vol. 26, p. 343 - 346
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • The first symmetrical tetrarheniumcyclodiyne type cluster containing phosphine ligands: Re4(μ-O)4Cl4[P(C6H4OMe-p)3]4
    作者:Sophia S. Lau、Phillip E. Fanwick、Richard A. Walton
    DOI:10.1039/a903367j
    日期:——
    The reactions of methanol solutions of cis-Re2(µ-O2CCH3)2Cl4(H2O)2 with PAr3 (Ar = Ph, C6H4Me-p, C6H4Me-m or C6H4Cl-p) afford the quadruply bonded dirhenium(IV,II) complexes Cl2(MeO)2ReReCl2(PAr3)2, whereas P(C6H4OMe-p)3 gives the complex Re4(µ-O)4Cl4[P(C6H4OMe-p)3]4, which X-ray crystallography has shown is the first symmetrical, neutral, tetrarheniumcyclodiyne type cluster containing phosphine ligands.
    顺式-Re2(µ-O2CCH3)2Cl4(H2O)2 的甲醇溶液与 PAr3(Ar = Ph、C6H4Me-p、C6H4Me-m 或 C6H4Cl-p)反应生成四键二(IV,II)配合物 Cl2(MeO)2ReReCl2(PAr3)2、而 P(C6H4OMe-p)3 则产生了 Re4(µ-O)4Cl4[P(C6H4OMe-p)3]4 复合物,X 射线晶体学研究表明,这是第一个含有膦配体的对称、中性、四环二炔型簇。
  • Dirhenium complexes of the tripodal phosphine CH3C(CH2PPh2)3 (triphos). The isolation and characterization of the confacial bioctahedral species [(triphos)Re(μ-X)3Re(triphos)]n+ (n=1 or 0)
    作者:Michael T. Costello、Paul W. Schrier、Phillip E. Fanwick、Richard A. Walton
    DOI:10.1016/s0020-1693(00)92321-1
    日期:1993.10
    The reactions of Re2(O2CCH3)2X4L2 (X = Cl or Br; L = py or H2O) with the tripodal phosphine CH3C(CH2PPh2)3 (triphos) in refluxing ethanol provide a route to the confacial bioctahedral dirhenium(II) complexes [Re2(mu-X)3(triphos)2]Y, where Y = Cl, Br or BPh4. The structural identity of the dirhenium cation has been established by X-ray crystallography on a crystal of composition [ReCl3(triphos)2]Cl. Crystal data at +20-degrees-C: triclinic space group P1BAR (No. 2), a=12.868(2), b=13.174(1), c=25.432(3) angstrom, alpha=94.761(8), beta=96.76(1), gamma=114.235(8)-degrees, V=3862(2) angstrom3, Z=2. The structure was refined by full-matrix least-squares to R=0.040 (R(w)=0.058) for 7523 data with I>3sigma(I). The confacial bioctahedral dirhenium(II) cation has a surprisingly long Re-Re distance (3.199(1) angstrom), which implies the absence of an Re-Re bond. The paramagnetism of these complexes accords with this result; all show well-defined contact-shifted H-1 NMR spectra and are ESR silent. The cations display four metal centered redox processes (two one-electron oxidations, two one-electron reductions); the first reduction can be accessed by cobaltocene to form the neutral complexes Re2(mu-X)3(triphos)2 in which there is an Re-2(3+) core present.
  • Shtemenko, A. V.; Bagirov, Sh. A.; Kotel'nikova, A. S., Russian Journal of Inorganic Chemistry, 1981, vol. 26, p. 58 - 60
    作者:Shtemenko, A. V.、Bagirov, Sh. A.、Kotel'nikova, A. S.、Lebedev, V. N.、Kazymov, O. I.、Alieva, A. I.
    DOI:——
    日期:——
  • Ara, Irene; Fanwick, Phillip E.; Walton, Richard A., Inorganic Chemistry, 1992, vol. 31, # 15, p. 3211 - 3215
    作者:Ara, Irene、Fanwick, Phillip E.、Walton, Richard A.
    DOI:——
    日期:——
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)